cell 682 words KG: disease
Contents

Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Disease

🧫 Cell Type Info
Cell Typedisease
Associated DiseasesALZHEIMER'S, ALZHEIMER'S DISEASE NEUROPATHOLOGY, ALZHEIMER'S
Related GenesACTB, AKT1, ATF6, ATG, ATG16L1, CASP3
Linked Hypotheses478 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

Related Hypotheses (199)

Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.68
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.68
...
Score: 0.68
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
RAB27A-dependent extracellular vesicle engineering for mitoc
Score: 0.67
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
Partial Neuronal Reprogramming via Modified Yamanaka Cocktai
Score: 0.67
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.67
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli
Score: 0.67
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
GAP43-mediated tunneling nanotube stabilization enhances neu
Score: 0.67
Complement C1q Subtype Switching
Score: 0.66
RNA Granule Nucleation Site Modulation
Score: 0.66
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.66
Temporal TET2-Mediated Hydroxymethylation Cycling
Score: 0.66
Mitochondrial RNA Granule Rescue Pathway
Score: 0.66
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
← Prevpg 6/10Next →

Related Analyses (30)

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism
clinical · proposed · Score: 0.40
Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in
clinical · proposed · Score: 0.40

See Also (12)

ABCA7 (Redirect)
redirect · KG edge: activates
A2M Gene
gene · KG edge: implicated_in
ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: interacts_with
ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: associated_with
ABCD3 Gene
gene · KG edge: activates

Knowledge Graph (12 edges)

SLC16A2 implicated_in disease
SLC16A1 implicated_in disease
GSS implicated_in disease
CYP2E1 implicated_in disease
AKT1 activates disease
ATF6 activates disease
ATG16L1 activates disease
CGAS activates disease
CFTR activates disease
CASP3 activates disease

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...